Harmonizing Heartbeats: The Mosaic of Cardiac Resynchronization Therapy Responders—A Comprehensive Exploration of Diverse Criteria and Predictors
Authors:
- Elke BoxhammerEBElke Boxhammer
- Sophie ZaunerSZSophie Zauner
- Johannes KrausJKJohannes Kraus
- Christian DingesCDChristian Dinges
- Christiana SchernthanerCSChristiana Schernthaner
- Franz DanmayrFDFranz Danmayr
- Tobias KolbitschTKTobias Kolbitsch
- Christina GranitzCGChristina Granitz
- Lukas J. MotlochLukas J. Motloch
- Matthias HammererMHMatthias Hammerer
- Michael LichtenauerMichael Lichtenauer
- Uta C. HoppeUHUta C. Hoppe
Open Access
- 21 August 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (16) , 4938
Abstract
Background: Heart failure (HF) remains a challenging healthcare issue necessitating innovative therapies like cardiac resynchronization–defibrillation therapy (CRT-D). However, the definition of a CRT-D response lacks uniformity, impeding effective clinical evaluation. This study explores diverse CRT-D responder definitions encompassing functional, echocardiographic and laboratory criteria. Materials & Methods: A single-center study involving 132 CRT-D patients scrutinized responder criteria including NYHA stage, LVEF increase and proBNP decrease. Statistical analyses such as Kaplan–Meier curves and Cox hazard regression were employed to evaluate responder characteristics and survival outcomes. Results: Responder rates varied across criteria, revealing nuanced patient profiles. CRT-D responders defined by NYHA decrease, LVEF increase or proBNP decrease exhibit improved survival rates after 2 and 3 years (p < 0.050). Young age, absence of recent myocardial infarction and normal right ventricular echocardiographic parameters emerge as predictors for positive response. In part, drug-based HF therapy correlates with increased responder rates. Cox regression identified LVEF ≥ 5% and proBNP decrease ≥ 25% as independent predictors of extended survival. Conclusions: CRT-D responder definitions exhibit considerable variability, emphasizing the need for a nuanced patient-centered approach. Factors like right ventricular function, drug therapy, atrial fibrillation and renal function influence responses. This study enriches our understanding of CRT-D response and contributes to the foundation for personalized HF management.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Impact of baseline right ventricular function on the response to cardiac resynchronization therapy – A meta-analysisHellenic Journal of Cardiology, 2023
- Right Ventricular–Pulmonary Artery Coupling in Cardiac Resynchronization Therapy: Evolution and PrognosisESC Heart Failure, 2022
- Utility of 6-Minute Walk Test to Predict Response to Cardiac Resynchronization Therapy in Patients With Mild Heart FailureThe American Journal of Cardiology, 2020
- Baseline Right Ventricular Dysfunction Predicts Worse Outcomes in Patients Undergoing Cardiac Resynchronization Therapy ImplantationJournal of Cardiac Failure, 2020
- Contrast-Induced Nephropathy After Cardiac Resynchronization Therapy Implant Impairs the Recovery of Ejection Fraction in RespondersESC Heart Failure, 2019
- Response to Cardiac Resynchronization Therapy Across Chronic Kidney Disease StagesJournal of Cardiac Failure, 2019
- Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutionsHeart Failure Reviews, 2018
- Strain Imaging to Predict Response to Cardiac Resynchronization Therapy: A Systematic Comparison of Strain Parameters Using Multiple Imaging TechniquesESC Heart Failure, 2018
- Changes in parameters of right ventricular function with cardiac resynchronization therapyClinical Cardiology, 2017
- Echo response and clinical outcome in CRT patientsNetherlands Heart Journal, 2015